Rhythm Pharmaceuticals Inc.’s recent filing unveils that its Corporate Controller & CAO German Christopher Paul unloaded Company’s shares for reported $15368.0 on Apr 02 ’24. In the deal valued at $41.76 per share,368 shares were sold. As a result of this transaction, German Christopher Paul now holds 795 shares worth roughly $34669.95.
Then, Shulman Joseph sold 18,235 shares, generating $735,600 in total proceeds. Upon selling the shares at $40.34, the Chief Technical Officer now owns 30 shares.
Before that, Lee Jennifer Kayden sold 18,235 shares. Rhythm Pharmaceuticals Inc. shares valued at $707,005 were divested by the EVP, Head of North America at a price of $38.77 per share. As a result of the transaction, Lee Jennifer Kayden now holds 6,852 shares, worth roughly $0.3 million.
Morgan Stanley upgraded its Rhythm Pharmaceuticals Inc. [RYTM] rating to an Overweight from a an Equal-weight in a research note published on December 19, 2023; the price target was increased to $55 from $29. A number of analysts have revised their coverage, including BofA Securities’s analysts, who increased its forecast for the stock in early August from “a Neutral” to “a Buy”. Goldman revised its rating on August 08, 2022. It rated RYTM as “a Buy” which previously was an “a Neutral”.
Price Performance Review of RYTM
On Tuesday, Rhythm Pharmaceuticals Inc. [NASDAQ:RYTM] saw its stock jump 4.33% to $43.61. Over the last five days, the stock has gained 8.89%. Rhythm Pharmaceuticals Inc. shares have fallen nearly -5.13% since the year began. Nevertheless, the stocks have risen 143.77% over the past one year. While a 52-week high of $52.57 was reached on 02/12/24, a 52-week low of $15.50 was recorded on 03/20/24. SMA at 50 days reached $43.85, while 200 days put it at $32.31. A total of 0.38 million shares were traded, compared to the trading of 0.49 million shares in the previous session.
Levels Of Support And Resistance For RYTM Stock
The 24-hour chart illustrates a support level at 41.71, which if violated will result in even more drops to 39.80. On the upside, there is a resistance level at 44.60. A further resistance level may holdings at 45.58. The Relative Strength Index (RSI) on the 14-day chart is 56.59, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.92, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 1.16%. Stochastics %K at 71.97% indicates the stock is a holding.
How much short interest is there in Rhythm Pharmaceuticals Inc.?
A steep rise in short interest was recorded in Rhythm Pharmaceuticals Inc. stocks on Mar 15, 2024, growing by 0.44 million shares to a total of 9.2 million shares. Yahoo Finance data shows the prior-month short interest on Feb 15, 2024 was 8.76 million shares. There was a rise of 4.78%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 24.55% of the overall stock float, the days-to-cover ratio (short ratio) rose to 16.29.
